Weekly Dose of Optimism #185
TLDR
- A curated optimism roundup covering Kalanick, Bezos, Copper One, cancer drug developments, Shinzen, and a featured essay.
Key Takeaways
- The issue spotlights Travis Kalanick and Jeff Bezos as central figures alongside scientific and business breakthroughs.
- Copper One appears as a notable company or development worth tracking in this edition.
- Cancer drug progress is included as one of the scientific breakthroughs highlighted this week.
- Shinzen Young features alongside other scientific or contemplative breakthroughs covered in the issue.
- The author singles out one essay as a personal favorite, treating editorial curation as a core feature.
Why It Matters
- Weekly Dose of Optimism is a recurring newsletter format that surfaces founder-relevant signals across science, business, and ideas in one place.
- Featuring Kalanick and Bezos alongside cancer drugs and Copper One suggests a deliberate mix of operator stories and hard-science wins.
- The “favorite essay” call-out points to the author using personal conviction as an editorial filter, not algorithmic aggregation.
· 2026-03-20 · Read the original